Recently, the possible beneficial outcomes of COVID-19 pneumonia by activating the Nrf2 pathway via chemical and ionizing radiation were analysed by Calabrese et al
First, a bacterial reverse mutation test (Ames test) assessed AOD9604s mutagenic potential using four histidine-dependent auxotrophic mutants of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) and one tryptophan-dependent auxotrophic mutant of Escherichia coli (WP2 uvrA), using both plate incorporation and pre-incubation methods at doses of 0, 1.6, 8, 40, 200, 1,000, and 2,000 g AOD9604/plate
As of 2026, BPC-157 is not approved by Health Canada for human or veterinary use and remains restricted to research-use-only contexts
How soon will I notice changes
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort